A transformation value creation strategy depends on a clear portfolio strategy and active portfolio management.
Category Archives: Pharmaceuticals and Medical Products
The FDA Regulatory Risks of Shifting to Foreign Suppliers
The FDA stays focused on the largest sourcing countries for drug ingredients are China and India which make up the majority of imports
Competitive Myopia: A Nearsighted View of the Competition
Companies suffer from competitive myopia when they define their competition too narrowly and acknowledge only direct and immediate competitors
Disruption: The curse of Competency Dependency
The curse of core compentency. When a competitor causes disruption, companies often limit decision-makers’ vision and which blinds them to other opportunities
Complacency – Success Breeds Failure | Business Culture
Complacency is the sense of security and comfort that derives from the belief that the business success that’s taken place in the past will continue indefinitely.
OEE: The perils of pervasive poor performance
OEE Overall Equipment Effectiveness. Developing an impactful and enduring manufacturing operations recovery strategy through OEE Segmentation.
Shingo Prize: Abbott Facility Receives Top International Award for Operational Excellence
#Abbott receives #Shingo Prize for Ireland plant
Johnson & Johnson and American College of Sports Medicine Form Global Alliance to Advance Human Health and Performance
#JNJ and ACSM, advance Human Health and Performance
Pharmaceutical packaging and plastic bottles innovative technology
#Pharma packaging and plastic bottles in high demand
Quality by Design: A Thriving Life Science Sector in Eastern NC
Quality by Design: Eastern NC beset by problems resulting from the failures of textiles, apparel and tobacco, now life sciences companies are blooming